Metabolism
Metabolism(代谢)
- PPAR(219)
- 5-alpha Reductase(11)
- 5-Lipoxygenase(11)
- Adenosine Deaminase(10)
- Aminopeptidase(15)
- C14ɑ demethylase(2)
- Carbonic Anhydrase(55)
- CETP(9)
- Cholesterol absorption(1)
- CPT1(2)
- CYP3A/CYP450(22)
- Dehydrogenase(43)
- DHFR(7)
- DGAT(10)
- Dopamine β-hydroxylase(10)
- Enolase(5)
- FAAH(38)
- Factor Xa(61)
- Ferroptosis(198)
- Folate Analogue(2)
- Glucokinase(18)
- HLE(1)
- HMG-CoA Reductase(37)
- HSP(100)
- IDO(46)
- KRAS-PDEδ(3)
- MAO(6)
- Metabolic Enzymes(6)
- Neuronal Metabolism(8)
- Oxidative Phosphorylation(26)
- P450(456)
- PDE(250)
- Phospholipase(130)
- Procollagen C Proteinase(1)
- Saccharometabolism(1)
- SCD(20)
- SGLT(29)
- TPH(4)
- Transferase(26)
- Energy Metabolism
- Inorganic Ions
- ALP(1)
- Carbohydrates(36)
- Uric Acid
- Muscle Metabolism
- MDA
- MPO
- Transaminase(3)
- Glutathione Reductase(1)
- Thioredoxin Reductase
- Catalase(15)
- monooxygenase(1)
- PKM2(1)
- Aldehyde dehydrogenase(1)
- Squalene synthase(1)
- Hydrolase(17)
- ornithine decarboxylase(1)
- Amino acid metabolism(3)
- phosphatases(103)
- Pyruvate kinase(13)
- Others(64)
- MGL(1)
- Galactosidase(2)
- 12-Lipoxygenase(1)
- Fatty Acid Synthase (FASN)(9)
- Dihydroorotate Dehydrogenase(13)
- Bile Acids & Microbiome(131)
- Bone Growth & Remodeling(55)
- Carbohydrate Metabolism(166)
- Cofactors & Vitamins(87)
- Dyslipidemias(109)
- Inborn Errors of Metabolism(100)
- Metabolic Syndrome(22)
- Necroptosis(12)
- Necrosis(19)
- Nutrient Sensing(14)
- Phosphodiesterase(34)
- Reproductive Biology(184)
- Thermogenesis(10)
- Sterol Biosynthesis(42)
- Prolyl Hydroxylation Enzymes(2)
- Biliary System(16)
- Metabolic Disease(5)
- Fat Mass and Obesity-associated Protein (FTO)(5)
- SHIP(1)
- FOXO
- Furin(1)
- Liposome(8)
- MetAP
- PGC-1α
- PI5P4K(1)
- Metabolic Diseases(2)
Metabolism 相关产品(3072)
- GC41655(±)19(20)-EDP EthanolamideCAS: 2123485-34-5纯度: >98.00%
An ω-3 endocannabinoid epoxide and CB receptor agonist
- GC41656(±)2-(14,15-Epoxyeicosatrienoyl) GlycerolCAS: 848667-56-1纯度: >95.00%
A cytochrome P450 metabolite of 2-AG
- GC41660(±)4(5)-EpDPA methyl esterCAS: 121818-29-9纯度: >98.00%
Stable precursor of (±)4(5)-EpDPA, a CYP450 metabolite of DHA
- GC41661(±)-4-hydroxy Propranolol β-D-GlucuronideCAS: 94731-13-2纯度: >90.00%
A metabolite of propranolol
- GC41691(2R)-Glycerol-O-β-D-galactopyranosideCAS: 16232-91-0纯度: >95.00%
A substrate for β-galactosidase and the lac operon
- GC41695(6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride)CAS: 150731-85-4纯度: >95.00%
A folic acid derivative
- GC41720(R)-Omeprazole (sodium salt)CAS: 161796-77-6纯度: >98.00%
An inactive isomer of a gastric proton pump inhibitor
- GC41736(S)-Dibutyl 3-Hydroxybutyl PhosphateCAS: 2108602-99-7纯度: >95.00%
A compound produced from tributyl phosphate
- GC417821,2-bis(heptanoylthio) GlycerophosphocholineCAS: 89019-63-6纯度: >95.00%
A substrate for PLA 2 s
- GC418581,4-dideoxy-1,4-imino-D-Arabinitol (hydrochloride)CAS: 100991-92-2纯度: >95.00%
A glycogen phosphorylase inhibitor
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41653 | (±)16(17)-DiHDPA | 1345275-27-5 | >95.00% | |
An epoxygenase metabolite of DHA | ||||
| GC41654 | (±)19(20)-DiHDPA | - | >98.00% | |
An epoxygenase metabolite of DHA | ||||
| GC41655 | (±)19(20)-EDP Ethanolamide | 2123485-34-5 | >98.00% | |
An ω-3 endocannabinoid epoxide and CB receptor agonist | ||||
| GC41656 | (±)2-(14,15-Epoxyeicosatrienoyl) Glycerol | 848667-56-1 | >95.00% | |
A cytochrome P450 metabolite of 2-AG | ||||
| GC41660 | (±)4(5)-EpDPA methyl ester | 121818-29-9 | >98.00% | |
Stable precursor of (±)4(5)-EpDPA, a CYP450 metabolite of DHA | ||||
| GC41661 | (±)-4-hydroxy Propranolol β-D-Glucuronide | 94731-13-2 | >90.00% | |
A metabolite of propranolol | ||||
| GC41662 | (±)5(6)-EET Ethanolamide | - | >95.00% | |
A potential cytochrome P450 metabolite of AEA | ||||
| GC41663 | (±)7(8)-DiHDPA | 168111-93-1 | >98.00% | |
A major metabolite of DHA | ||||
| GC41665 | (±)8(9)-EET Ethanolamide | - | >98.00% | |
A cytochrome P450 metabolite of AEA | ||||
| GC41671 | (±)-Equol 4'-sulfate (sodium salt) | 1189685-28-6 | >90.00% | |
A metabolite of (±)-equol | ||||
| GC41691 | (2R)-Glycerol-O-β-D-galactopyranoside | 16232-91-0 | >95.00% | |
A substrate for β-galactosidase and the lac operon | ||||
| GC41694 | (3S)-hydroxy Quinidine | 53467-23-5 | >98.00% | |
An active quinidine metabolite | ||||
| GC41695 | (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride) | 150731-85-4 | >95.00% | |
A folic acid derivative | ||||
| GC41720 | (R)-Omeprazole (sodium salt) | 161796-77-6 | >98.00% | |
An inactive isomer of a gastric proton pump inhibitor | ||||
| GC41722 | (R,S)-Carvedilol Glucuronide | 114869-83-9 | >95.00% | |
A phase II metabolite of carvedilol | ||||
| GC41736 | (S)-Dibutyl 3-Hydroxybutyl Phosphate | 2108602-99-7 | >95.00% | |
A compound produced from tributyl phosphate | ||||
| GC41746 | [Ser4,Ile8]-Oxytocin (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide | ||||
| GC41782 | 1,2-bis(heptanoylthio) Glycerophosphocholine | 89019-63-6 | >95.00% | |
A substrate for PLA 2 s | ||||
| GC41808 | 1,2-Dioctanoyl PC | 19191-91-4 | >99.00% | |
A short chain analog of phosphatidylcholine | ||||
| GC41837 | 1,3,7-Trimethyluric Acid | 5415-44-1 | >98.00% | |
A metabolite of caffeine | ||||
| GC41846 | 1,3-Dioctanoyl-2-Oleoyl-rac-glycerol | 109796-58-9 | >98.00% | |
A triacylglycerol | ||||
| GC41849 | 1,3-Dipalmitoleoyl-rac-glycerol | 106352-09-4 | >98.00% | |
A diacylglycerol | ||||
| GC41850 | 1,3-Dipalmitoyl-2-Eicosapentaenoyl-rac-glycerol | 148691-18-3 | >98.00% | |
A triacylglycerol | ||||
| GC41858 | 1,4-dideoxy-1,4-imino-D-Arabinitol (hydrochloride) | 100991-92-2 | >95.00% | |
A glycogen phosphorylase inhibitor | ||||